52 completed, 9 unknown, 7 terminated. 25 Phase 4, 22 Phase 3, 12 Phase 2, 5 Not applicable, 3 Phase 1.
Follow epoetin beta: new trials by email Literature Review of epoetin beta trials Research Report on epoetin beta
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial Anemia Control Model (ACM), IV iron, Erythropoiesis-Stimulating Agent (ESA) - Anemia, End Stage Renal Disease | Not applicable | Terminated | Vifor Fresenius Medical Care Renal Pharma | 88 | 2018-12-10 | 2020-01-07 |
| Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome Erythropoietin, Normal saline - Premature Infants, Intracranial Hemorrhages | Phase 3 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 400 | 2017-04-10 | 2017-10-02 |
| Treatment Response in Dialysis Anaemia Iron sucrose, Erythopoietin stimulating agent - Anaemia, Haemodialysis | Phase 4 | Completed | Imperial College Healthcare NHS Trust | 197 | 2015-07-01 | 2021-04-14 |
| Predictors of Response to Iron and Erythropoietin Stimulating Agents Iron Sucrose Solution for Injection, Epoetin Beta - Renal Failure Chronic, Anemia | Phase 4 | Completed | Imperial College London | 197 | 2015-06-03 | 2019-07-05 |
| Paricalcitol Improves Anemia of Inflammation Paricalcitol, Epoetin beta, Placebo - Anemia | Phase 4 | Terminated | Hospital Son Espases | 19 | 2014-12-01 | 2024-12-09 |
| A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS) Epoetin beta - Myelodysplastic Syndromes | Phase 4 | Completed | Hoffmann-La Roche | 100 | 2014-08-06 | 2020-04-24 |
| Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants recombinant human Erythropoietin, Placebo - Intraventricular Hemorrhage of Prematurity | Phase 3 | Unknown | University of Zurich | 120 | 2014-03-01 | 2018-11-23 |
| Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis EPO, Normal saline - Premature Infant | Phase 2 | Completed | Zhengzhou University | 1285 | 2014-01-01 | 2019-04-19 |
| Non-erythroid Effects of Erythropoietin on Cognitive Function and Exercise Capacity in Humans Erythropoietin (Epoetin beta), Placebo - Healthy | Phase 1 / Phase 2 | Unknown | University of Zurich | 32 | 2013-02-01 | 2013-06-28 |
| Renal Effects of Erythropoietin in Humans Erythropoietin (Epoetin-beta, NeoRecormon®), Placebo - Renal Effects | Phase 1 | Completed | University of Copenhagen | 16 | 2012-03-01 | 2013-11-05 |
| Comparison Among Erythropoietin Stimulating Agents Epoetin alpha or beta (Epoetin group), Darbepoetin alfa, Methoxy polyethylene glycol-epoetin beta - Anemia of End Stage Renal Disease | Phase 4 | Completed | Hamad Medical Corporation | 327 | 2012-03-01 | 2017-09-13 |
| Prevention of Contrast Induced Nephropathy by Erythropoietin Epoetin beta, Saline 0.9% - Diabetes, Chronic Kidney Insufficiency | Phase 3 | Unknown | Western Galilee Hospital-Nahariya | 142 | 2011-08-01 | 2012-10-10 |
| Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA) cera, darbepoetin, epoetin-beta, ESA - Renal Anemia | Phase 4 | Completed | University Hospital, Basel, Switzerland | 9 | 2011-01-01 | 2011-10-19 |
| Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality. Lenalidomide, Epoetin beta - Myelodysplastic Syndromes | Phase 2 | Completed | Groupe Francophone des Myelodysplasies | 132 | 2010-07-01 | 2016-11-08 |
| Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS) Epoetin beta (NeoRecormon) - Myelodysplastic Syndromes | Phase 2 | Completed | Groupe Francophone des Myelodysplasies | 50 | 2010-06-01 | 2015-04-29 |
| An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST) epoetin beta [NeoRecormon] - Anemia, Neoplasms | Completed | Hoffmann-La Roche | 1060 | 2010-01-01 | 2015-10-02 | |
| Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery beta erythropoietin, placebo - Acute Renal Failure | Phase 3 | Unknown | Thammasat University | 200 | 2010-01-01 | 2010-02-10 |
| The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis Erythropoietin - Multiple Sclerosis (Primary or Secondary Progressive Phase). | Phase 2 | Unknown | Copenhagen University Hospital, Rigshospitalet | 56 | 2009-11-01 | 2011-08-08 |
| Study of Erythropoietin (EPO) Administration Schedule recomon (Epoetin Beta) - Chronic Renal Failure, Anaemia | Phase 4 | Completed | JW Pharmaceutical | 60 | 2009-10-01 | 2014-05-14 |
| A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia. epoetin beta, methoxy polyethylene glycol-epoetin beta [Mircera] - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 281 | 2009-07-01 | 2016-11-02 |
Showing 20 of 68. Sign in to see all of them.
Anemia (41) · Kidney Failure, Chronic (5) · Myelodysplastic Syndromes (5) · Hepatitis C, Chronic (4) · Renal Insufficiency, Chronic (3) · Acute Kidney Injury (2) · Kidney Diseases (2) · Neoplasms (2) · Premature Birth (2) · Renal Insufficiency (2) · Anemia, Refractory, with Excess of Blasts (1) · Bronchiolitis Obliterans Syndrome (1) · Cerebral Palsy (1) · Delayed Graft Function (1) · Diabetes Mellitus (1)
Hoffmann-La Roche (26) · Groupe Francophone des Myelodysplasies (3) · Centre Hospitalier Universitaire, Amiens (2) · Chugai Pharmaceutical (2) · Seoul National University Bundang Hospital (2) · University of Zurich (2) · AGO Study Group (1) · Affymax (1) · Centre Hospital Regional Universitaire de Limoges (1) · Charite University, Berlin, Germany (1) · Claude Bernard University (1) · Copenhagen University Hospital, Rigshospitalet (1) · Deutsches Herzzentrum Muenchen (1) · Dr. Conrado Fernandez (1) · First Affiliated Hospital Xi'an Jiaotong University (1)
France (18) · Spain (10) · Germany (8) · United Kingdom (8) · Italy (7) · Thailand (6) · Australia (5) · Denmark (5) · Poland (5) · Russia (5) · Austria (4) · China (4) · Czechia (4) · Greece (4) · Mexico (4)
Adis Tasanarong, MD (1) · Albert Schomig, MD (1) · Changlian Zhu, PhD (1) · Claude Gardin, MD (1) · Conrado M Fernandez-Rodriguez (1) · Damien Ashby, MBBS (1) · Damien Dr Ashby, MBBS (1) · Damien Pouessel, MD (1) · Daryl Bendel, MBChB MBA (1) · Ebenhard Ritz, Prof. Dr. (1)
PMID 36791280, PMID 39301879, PMID 17108342, PMID 17261422, PMID 18565240, PMID 19630971, PMID 20377423, PMID 20642691, PMID 20736448, PMID 20849244, PMID 21818622, PMID 22193388, PMID 23343061, PMID 23343062, PMID 23829828, PMID 24360571, PMID 25157725, PMID 25534356, PMID 26626993, PMID 26965694, PMID 27130143, PMID 27187300, PMID 27229713, PMID 27244862, PMID 28109258, PMID 31420350, PMID 32771013, PMID 33076939, PMID 36459138